Specializing in the areas of Urologic Oncology and Andrology, she has completed a master's degree in Uro-Oncology and is currently pursuing a doctorate in the same field.
Dr. Fernández Hernández graduated in Medicine from the Autonomous University of Madrid and specialized in Urology at the San Carlos University Clinical Hospital in Madrid. During her training, she showed particular interest in the areas of Urologic Oncology and Andrology. She completed a residency in the Andrology and Reconstructive Surgery Unit at the Bellvitge University Hospital (Barcelona) and subsequently earned three master's degrees, obtaining the title of Expert in Uro-Oncology in all of them.
Currently, he also practices at the University Hospital of Torrejón (Madrid). In 2022, he obtained the European title and certification: Fellow of the European Board of Urology (FEBU). He is currently pursuing a doctorate in Urologic Oncology at the Complutense University of Madrid.
She currently specializes in Urologic Oncology and Andrology, specifically in the management of erectile dysfunction and penile prosthetic surgery.
Currently, he is a member of the Spanish Association of Urology (AEU) and the European Association of Urology (EAU).
2024
– Vives Dilme R, Gómez Rivas J, Fernández Hernández L, De la Parra Sánchez I, Moreno Sierra J. Oncological outcomes in robot-assisted radical prostatectomy: the value of PSA density as a preoperative predictive factor. Cancers. Oncological outcomes in robot-assisted radical prostatectomy: the value of PSA density as a preoperative predictive factor. Ther Adv Urol 2024; 7;16:17562872241229250.
– García Rico E, Carrión DM, Serrano González J, Ortega Polledo LE, Fernández Hernández L. Recurrent uretero-sciatic herniation causing right obstructive uropathy. Cureus 2024; 28;16(3):e57128. doi: 10.7759/cureus.57128.
– Cabezón Gutiérrez L, Custodio Cabellos S, Pacheco Barcia V, Palka Kotlowska M, Fernández Hernández L, Fernández del Álamo J, Oliveros Acebes E. Prognostic value of germline mutations in metastatic hormone-sensitive prostate cancer (mHSPC) Urol Oncol 2024; 42(10):331.e13-331.e24. doi:10.1016/j.urolonc.2024.05.010.
2022
– Méndez Rubio S, Laso Martín S, Jerez Izquierdo T, Lorenzo García C, López Pérez E, Vives Dilme R, Fernández Hernández L, Méndez Cea B, Moreno Sierra J, Virseda Chamorro M, Salinas Casado J. Urodynamics of RAO in Guillain-Barré syndrome post-infection by Sars-Cov-2 coronavirus. A bibliographic review. Arch Esp Urol. 2022;75(1):7-18. PMID: 35173070.
– Gómez Rivas J, Fernández Hernández L, Abad López P, Moreno Sierra J. Androgen deprivation therapy in localized prostate cancer. Current status and future trends. Actas urológicas españolas 2022. https://doi.org/10.1016/j.acuro.2022.04.007
– Gómez Rivas J, Fernández Hernández L, Moreno Sierra J. Optimization of the management of bone adverse effects resulting from androgen deprivation therapy in the setting of castration-non-resistant prostate cancer. Actas urológicas españolas 2022. https://doi.org/10.1016/j.acuro.2022.04.006
– Gómez Rivas J, Fernández Hernández L, Puente Vázquez J, Vidal Casinello N, Galante Romo MI, Redondo González E, Sanmamed Salgado N, Vives Dilme R, Moreno Sierra J. Where do we stand in the management of oligometastatic prostate cancer? A comprehensive review. Cancer (basel). 2022;14(8). DOI: 10.3390/cancers14082017.
– Vives Dilme R, Gómez Rivas J, Fernández Hernández L, Ibáñez Vázquez L, Moreno Sierra J. Improving oncological outcomes after robot-assisted radical prostatectomy: what novel tools do we have? Mini-invasive Surg 2022;6:53. DOI: 10.20517/2574-1225.2022.48.
– Fernández Hernández L, Gómez Rivas J, Blázquez Izquierdo J, Moreno Sierra J. Pyeloenteric fistula. The urinary fistula book. Eds. René Sotelo, Charles Polotti and Juan Arriaga. Springer Publishing 2022.
2021
– Fernández Hernández L, Redondo González E, Vives Dilme R, Vidal Casinello N, Puente Vázquez J, Fernández Montarroso L, Galante Romo MI, Moreno Sierra J. Update on the management of non-metastatic castration-resistant prostate cancer. Medical Research Archives. Vol 9, issue 3. 2021. DOI: https://doi.org/10.18103/mra.v9i3.2348.
– Vives Dilme R, Galante Romo MI, Fernández Hernández L, Redondo González E, Galindo Hererro I, Senovilla Pérez JL, Ciappara Paniagua M, Fernández Montarroso L, Moreno Sierra J. Robotic radical prostatectomy in the 21st century: evolution of experience. Medical Research Archives. Vol 9, issue 5. 2021. DOI: https://doi.org/10.18103/mra.v9i5.2408.
– Vidal Casinello N, Gómez Rivas J, Fernández Hernández L, Moreno Sierra J, Puente Vázquez J. The past, present and future of non-metastatic castration-resistant prostate cancer (NMCRPC): a narrative review. Precision Cancer Medicine 2021. DOI: https://doi.org/10.21037/pcm-21-34.
– Fernández Hernández L. Special urodynamic techniques: urethral profile, ambulatory urodynamics and selective electromyography. Chapter of the Master's Degree in Advanced Surgery of Urinary Incontinence and Pelvic Floor I Edition 2021 of the Complutense University of Madrid.
– Fernández Hernández L, Galante Romo MI. Natural evolution of prostate cancer. Chapter of the Master's Degree in Multidisciplinary Approach in
Prostate cancer I Edition 2021 of the Complutense University of Madrid.
